1. Home
  2. JBTM vs AMRX Comparison

JBTM vs AMRX Comparison

Compare JBTM & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBT Marel Corporation

JBTM

JBT Marel Corporation

HOLD

Current Price

$107.75

Market Cap

5.6B

Sector

N/A

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$20.44

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBTM
AMRX
Founded
1994
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.4B
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
JBTM
AMRX
Price
$107.75
$20.44
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
★ $167.06
$22.71
AVG Volume (30 Days)
416.9K
★ 2.7M
Earning Date
11-02-2026
11-03-2026
Dividend Yield
★ 0.37%
N/A
EPS Growth
N/A
★ 157.89
EPS
★ 1.40
0.37
Revenue
★ $3,798,200,000.00
N/A
Revenue This Year
$5.89
$4.53
Revenue Next Year
$5.03
$9.13
P/E Ratio
$76.55
★ $54.59
Revenue Growth
★ 121.34
N/A
52 Week Low
$102.97
$9.99
52 Week High
$170.19
$21.18

Technical Indicators

Market Signals
Indicator
JBTM
AMRX
Relative Strength Index (RSI) 48.86 62.42
Support Level $103.26 $16.59
Resistance Level $114.74 $20.98
Average True Range (ATR) 2.87 0.62
MACD 0.52 -0.02
Stochastic Oscillator 64.87 92.84

Price Performance

Historical Comparison
JBTM
AMRX

About JBTM JBT Marel Corporation

JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: